Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The TPL Group Files Appeal to Reverse Markman Claim Construction for US ‘584 Patent in MMP™ Portfolio
TPL must be very confident of a successful appeal.. I trust TTC to get this right... If they are as good as advertised, they just may get it reversed.
Share
New Message
Please login to post a reply